BioCentury
ARTICLE | Company News

Altor BioScience, Shenzhen Beike Biotechnology deal

September 22, 2014 7:00 AM UTC

Altor granted Shenzhen Beike rights in China to develop and commercialize ALT-803 for human indications. The IL-15 mutant agonist complexed to an Fc fusion protein of IL-15 receptor a-chain ( IL-15RA...